• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular pathogenesis of Fanconi anemia

Research Project

Project/Area Number 16590928
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionGunma University

Principal Investigator

YAMASHITA Takayuki  Gunma University, Institute for Molecular and Cellular Regulation, Professor, 生体調節研究所, 教授 (10166671)

Co-Investigator(Kenkyū-buntansha) ODA Tsukasa  Gunma University, Institute for Molecular and Cellular Regulation, Assistant Professor, 助手 (10323643)
Project Period (FY) 2004 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,700,000 (Direct Cost: ¥3,700,000)
Fiscal Year 2005: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 2004: ¥2,700,000 (Direct Cost: ¥2,700,000)
KeywordsFanconi anemia / bone marrow failure / DNA repair / genetic reversion / somatic mosaicism / methylation / tumor suppressor gene / シャペロン / ユビキチン化 / プロテアソーム
Research Abstract

Fanconi anemia (FA) is a genetically heterogeneous inherited disorder characterized by bone marrow failure and congenital anomalies. Although an increasing number of reports suggest that reverse mosaicism noted in peripheral blood lymphocytes (PBL) is associated with mild hematopoietic failure in FA, direct examination of myeloid cells have been done in few cases. We found a patient with prolonged mild pancytopenia in whom proliferation of revertant cells was detected in mature myeloid cells but not in PBL. While this patient had inherited heterozygous mutations, 2546delC and 3720-3724del, in the major Fanconi anemia gene FANCA, lymphoblastoid cells from the patient had 2546C>T instead of 2546delC, resulting in expression of a functional missense protein. Since the identical reversion was detected in polymorphonuclear granulocytes and mononuclear phagocytes, sustained hematopoiesis in the patient is attributed to selective growth advantage of revertant myeloid cells. It is noteworthy t … More hat such a myeloid lineage-selective mosaicism is overlooked in routine examination of PBL. Recognition of this status will expand the role of reverse mosaicism in the pathophysiology of FA. Bone marrow failure in FA often shows progression to myelodysplastic syndrome (MDS) and leukemia, which may be attributed to mutations of oncogenes and tumor suppressor genes based on DNA repair deficiency. However, specific mutations of these genes have not been identified in FA leukemic cells. We hypothesized that epigenetic abnormalities may be associated with the pathophysiology of FA. To address this question, we analyzed promoter methylation of five tumor suppressor genes, p15, p16. DAP kinase, RAR-β, E-cadherin. The results showed that 8 of 11 patients (72.7%) had hypermethylation in one or more of these genes. The methylation abnormalities were observed more frequently in patients with MDS than in those without MDS. These results suggest that epigenetic abnormalities might be involbed in leukmogensis in FA. Less

Report

(3 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • Research Products

    (5 results)

All 2006 2004

All Journal Article (3 results) Book (2 results)

  • [Journal Article] Myeloid lineage-selective growth of revertant cells in Fanconi anemia.2006

    • Author(s)
      Hamanoue S, Oda T, Yamashita T et al.
    • Journal Title

      British Journal of Haematology 132

      Pages: 630-635

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Annual Research Report 2005 Final Research Report Summary
  • [Journal Article] Identification and characterization of the major Fanconi anemia gene FANCA in the Japanese population.2004

    • Author(s)
      Yagasaki H, Yamashita T, et al.
    • Journal Title

      Human Mutation 24

      Pages: 481-490

    • Related Report
      2004 Annual Research Report
  • [Journal Article] ABT1-associated protein (ABTAP), a novel nuclear protein conserved from yeast to mammals, represses transcriptional activation by ABT1.2004

    • Author(s)
      Oda T, Yamashita T, et al.
    • Journal Title

      Journal of Cellular Biochemistry 93

      Pages: 788-806

    • Related Report
      2004 Annual Research Report
  • [Book] Molecular Mechanisms of Fanconi Anemia2006

    • Author(s)
      Yamashita T, et a1.
    • Total Pages
      121
    • Publisher
      Landes Bioscience/ Eurekah. com
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2005 Final Research Report Summary
  • [Book] Molecular Mechanisms of Fanconi Anemia2006

    • Author(s)
      Yamashita T, et al.
    • Total Pages
      121
    • Publisher
      Landes Bioscience/Eurekah.com
    • Related Report
      2005 Annual Research Report

URL: 

Published: 2004-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi